Targeting AML with Multi-Antigen Specific T Cells Engineered to Express a CAR Specific for SSX2 Peptide 41-49

被引：0
|
作者：
Pezzella, Gloria [1 ]
Achour, Achouak [1 ]
Yvon, Eric S. [2 ]
Bollard, Catherine M. [1 ,2 ]
Toner, Keri [1 ,2 ]
机构：
[1] Childrens Natl Hosp, Washington, DC USA
[2] George Washington Univ, Washington, DC USA
来源：
MOLECULAR THERAPY | 2024年 / 32卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
142
引用
收藏
页码：77 / 78
页数：2
相关论文
共 50 条
  • [11] Generation of multi-antigen specific T cells for ovarian cancer using Prussian Blue nanoparticles and photothermal therapy
    Grundy, Erin E.
    Lee, Abigail
    Chin, Samantha
    Hadley, Melissa
    Schmidt, Danielle
    Wang, Loretta
    Cox, Olivia
    Omar, Khadra
    Bollard, Catherine M.
    Fernandes, Rohan
    Chiappinelli, Katherine B.
    CANCER RESEARCH, 2024, 84 (06)
  • [12] Immunotherapy of Hepatocellular Carcinoma With T Cells Engineered To Express Glypican-3-Specific Chimeric Antigen Receptors
    Li, Wenpeng
    Guo Linjie
    Ekaterina, Marinova
    Gianpietro, Dotti
    Stephen, Gottschalk
    Leonid, Metelitsa
    Andras, Heczey
    MOLECULAR THERAPY, 2015, 23 : S164 - S165
  • [13] DNA vaccines encoding altered peptide ligands for SSX2 enhance epitope-specific CD8+ T-cell immune responses
    Smith, Heath A.
    Rekoske, Brian T.
    McNeel, Douglas G.
    VACCINE, 2014, 32 (15) : 1707 - 1715
  • [14] Vaccines Targeting the Cancer-testis Antigen SSX-2 Elicit HLA-A2 Epitope-specific Cytolytic T Cells
    Smith, Heath A.
    McNeel, Douglas G.
    JOURNAL OF IMMUNOTHERAPY, 2011, 34 (08) : 569 - 580
  • [15] Dendritic Cells Engineered to Express Defined Allo-HLA Peptide Complexes Induce Antigen-specific Cytotoxic T Cells Efficiently Killing Tumour Cells
    Stronen, E.
    Abrahamsen, I. W.
    Gaudernack, G.
    WAlchli, S.
    Munthe, E.
    Buus, S.
    Johansen, F. -E.
    Lund-Johansen, F.
    Olweus, J.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2009, 69 (04) : 319 - 328
  • [16] TARGETING ENGINEERED INTERLEUKIN-2 (IL-2) TO ANTIGEN SPECIFIC T CELLS VIA NOVEL BIOLOGIC PLATFORMS
    Moniz, Raymond
    Vakkasoglu, Ahmet
    Merazga, Zohra
    Daigneault, Tina
    Quayle, Steve
    Girgis, Natasha
    Seidel, Ronald
    Ross, John
    Low, Simon
    Suri, Anish
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A828 - A828
  • [17] Specific lysis of multiple myeloma cells by T-cells engineered to express a chimeric immune receptor targeting HM 1.24
    Topp, MS
    Hummel, H
    Kuntz, G
    Neff, C
    Einsele, H
    BONE MARROW TRANSPLANTATION, 2004, 33 : S157 - S158
  • [18] Efficient Targeting of T Cell Malignancies In Vitro and In Vivo Using CD4-Specific Chimeric Antigen Receptor (CAR)-Engineered NK Cells
    Pinz, Kevin G.
    Yakaboski, Elizabeth
    Jares, Alexander
    Liu, Hua
    Firor, Amelia E.
    Wada, Masayuki
    Leung, Lai-Han
    Jiang, Xun
    Ma, Yupo
    MOLECULAR THERAPY, 2016, 24 : S256 - S257
  • [19] GD2-specific chimeric antigen receptor T cells targeting retinoblastoma
    Sujjitjoon, Jatuporn
    Atchaneeyasakul, La-ong Sri
    Tsao, Shih-Ting
    Sayour, Elias
    Yenchitsomanus, Pa-thai
    Chang, Lung-Ji
    CANCER RESEARCH, 2015, 75
  • [20] Targeting of Ewing sarcoma by CAR-reengineered GD2-specific T cells
    Kailayangiri, Sareetha
    Altvater, Bianca
    Meltzer, Jutta
    Leuchte, Katharina
    Hotfilder, Marc
    Juergens, Heribert
    Rossig, Claudia
    CANCER RESEARCH, 2011, 71
12345